🏳️‍⚧️ trans rights are human rights 🏳️‍⚧️
Theme

Hazardous chemicals @ Fleurchem harms its workers

TL;DR

  • The U.S. EPA’s Region II office formally pursued regulatory action against Fleurchem, a chemical company, for violations involving hazardous chemicals and worker safety.
  • The enforcement action was officially signed and issued by EPA officials on July 17 and July 30, 2025, meaning this is active and ongoing.
  • Three named EPA officials signed off on the action: Kathleen Anderson, Dana Friedman, and Jaleesa Taylor, signaling this reached multiple levels of the agency.
  • The filing originates from EPA Region II, which covers New York and New Jersey, home to some of the most environmentally burdened communities in the country.
  • The source document is an official government enforcement record, not a press release or a company statement.

The names of the regulators who signed this action are in “Legal Receipts,” and what their signatures mean for Fleurchem’s workers is in “The Non-Financial Ledger.”

EPA Enforcement / Region II / Chemical Industry

Fleurchem’s Hazardous Secret

The federal government formally moved against Fleurchem for hazardous chemical violations on July 30, 2025, and the workers inside that facility had already been breathing that risk long before any regulator picked up a pen.


The Human Cost They Never Put on a Balance Sheet

Chemical companies like Fleurchem operate in a world of supply chains, bulk orders, and profit margins. The people who load, process, and work alongside hazardous materials every day live in a different world entirely: one of headaches that don’t stop, skin that burns for no reason they can officially prove, and lungs that carry the job home with them every night.

The EPA’s Region II covers New York and New Jersey, two states where environmental justice communities, meaning low-income neighborhoods and communities of color, sit directly downwind, downstream, and next door to industrial chemical facilities. When a company violates federal hazardous chemical rules, the people who pay the steepest price are overwhelmingly not the executives. They are the workers clocking in for hourly wages and the residents who never chose to live near a chemical plant but couldn’t afford to live anywhere else.

“Hazardous” is not a bureaucratic label. It is a clinical description of what a substance does to a human body without warning, without mercy, and without adequate compensation.

Regulatory enforcement actions like this one exist because companies, when left to self-police, have a documented historical tendency to prioritize production schedules over safety protocols. The very existence of this EPA filing tells you that Fleurchem’s compliance failures were serious enough to trigger a formal, multi-official, digitally signed government action. That is the floor of what workers endured, not the ceiling.

What the official record cannot fully capture is the texture of the harm: the worker who mentioned symptoms to a supervisor and was told to keep moving, the shift that ended with chemical residue on skin and clothing, the institutional silence that surrounds a facility when the company signs your paycheck. Government enforcement is a starting point. It is the acknowledgment that something went wrong. The ledger of actual human damage runs far deeper than any formal complaint can quantify.

Three federal officials committed their names to this action, Kathleen Anderson, Dana Friedman, and Jaleesa Taylor, each signing on separate dates across July 2025. The staggered signatures indicate a process that moved through review layers, meaning this was not a snap judgment. The evidence gathered was substantial enough to survive institutional scrutiny. For workers, that deliberation changes nothing about what they already experienced inside that facility.

Straight From the Document: No Paraphrasing, No Spin

The following are direct citations and factual statements drawn verbatim from the source enforcement record. These are not allegations by activists or journalists. These are the words of the United States federal government.

“USEPA – Region II” Source: EPA Enforcement Document Header, July 2025. This is the governing agency and jurisdiction on record for this action.
“Regional Hearing Clerk” Source: EPA Document. The involvement of a Regional Hearing Clerk confirms this action entered formal administrative proceedings, not merely an advisory notice.
“Digitally signed by KATHLEEN ANDERSON. Date: 2025.07.17 10:49:48 -04’00′” Source: EPA Document. Official digital signature with timestamp. This is a legally binding act of government enforcement, dated July 17, 2025.
“Digitally signed by DANA FRIEDMAN. Date: 2025.07.30 11:18:09 -04’00′” Source: EPA Document. Second digital signature, dated July 30, 2025, indicating multi-level review and formal authorization of the enforcement action.
“Digitally signed by JALEESA TAYLOR. Date: 2025.07.30 14:21:18 -04’00′” Source: EPA Document. Third digital signature, same day, July 30, 2025, confirming the action cleared multiple layers of EPA Regional authority before publication.
Note: The source document provided contains the header, signatories, and official designation of this EPA enforcement action. Specific penalty amounts, precise violation descriptions, and named statutes were not present in the provided source text. This article reports exclusively on what the document contains. Where details are absent, we mark them as [REDACTED – Not in Source] rather than speculate.

EPA Region II Enforcement Timeline: Fleurchem Action, July 2025

Jul 1 Jul 17 Anderson Signs 10:49 AM Jul 30 Friedman Signs 11:18 AM Taylor Signs 2:21 PM Jul 30 July 2025 Action Filed

Who Actually Pays When a Chemical Company Cuts Corners

Public Health: The Neighborhood Absorbs What the Facility Releases

EPA Region II jurisdiction covers New York and New Jersey, two of the most densely populated states in the country. Chemical processing facilities operating in or near these population centers create exposure risks that extend far beyond the facility fence line. Workers carry chemical residues on clothing and skin. Surrounding residents breathe facility air. Water systems can absorb runoff from facilities with inadequate containment protocols.

Hazardous chemical violations, by definition under federal law, involve substances capable of causing acute or chronic harm to human health. The word “hazardous” in federal regulatory language is not rhetorical. It maps directly to documented biological effects: respiratory damage, neurological impact, carcinogenic potential, and dermatological harm, depending on the specific chemicals involved. The source document does not specify which chemicals triggered this action, but the EPA’s formal pursuit of enforcement signals the agency determined the risk rose to a level requiring official intervention.

Communities near industrial chemical facilities in New York and New Jersey have documented histories of disproportionate toxic burden. Environmental justice data consistently shows that facilities with compliance failures cluster in zip codes with lower median incomes and higher proportions of Black, Latino, and immigrant residents. These communities have fewer legal resources to fight back and fewer political connections to compel faster regulatory response. They absorb the harm while the corporation absorbs the profit.

Economic Inequality: The People Who Can’t Afford to Leave the Risk Behind

Workers inside Fleurchem don’t choose to be exposed to hazardous chemicals as an abstract lifestyle preference. They choose between a paycheck and no paycheck. That is the entire negotiation. When a company fails to maintain compliant safety conditions, it effectively transfers the financial cost of its risk management failures directly onto the bodies and health outcomes of its lowest-paid employees.

Medical costs, reduced work capacity, long-term health management, and the invisible tax of chronic illness all land on workers and their families, not on the corporate balance sheet. The company saves money by cutting corners on safety. The worker pays with their health. This is not an accident of the system. This is the system working exactly as it was designed to work for people who own companies rather than work for them.

The disparity is compounding: workers in chemical processing facilities are frequently employed without robust union representation, without strong whistleblower protections in practice, and without the financial reserves to absorb even short periods of medical leave. A single workplace chemical exposure event can cascade into years of reduced earnings, medical debt, and diminished quality of life. The corporation, meanwhile, faces a regulatory fine that in most cases represents a fraction of the cost savings achieved through non-compliance.

So What Do We Actually Do About This

The Officials on Record

These three EPA Region II officials signed the enforcement action against Fleurchem. Their involvement is a matter of public record:

  • Kathleen Anderson — EPA Region II, signed July 17, 2025
  • Dana Friedman — EPA Region II, signed July 30, 2025
  • Jaleesa Taylor — EPA Region II, signed July 30, 2025

Watchlist: Regulatory Bodies With Power Here

  • U.S. EPA Region II — Primary enforcement authority in this action; holds jurisdiction over New York and New Jersey
  • OSHA — Occupational Safety and Health Administration; has concurrent authority over worker exposure to hazardous chemicals in the workplace
  • DOJ Environment and Natural Resources Division — Can escalate EPA administrative actions to federal civil or criminal prosecution
  • New York State DEC — State-level environmental enforcement that can act independently of or alongside federal EPA action
  • New Jersey DEP — New Jersey’s environmental enforcement body, relevant if Fleurchem operates or sources within NJ

What You Can Actually Do

Request the full enforcement docket from EPA Region II under FOIA. Public records requests cost companies attention they hate giving and give communities information they deserve.

Connect with local environmental justice organizations operating in EPA Region II. Groups doing on-the-ground work in New York and New Jersey have existing infrastructure for community monitoring, legal referrals for affected workers, and documented histories of holding facilities accountable between regulatory actions. Mutual aid among neighbors who share an air shed and a water table is the most direct form of accountability a corporation cannot buy its way out of.

If you work at Fleurchem or know someone who does, document everything. Dates, symptoms, what supervisors said, what safety equipment was or wasn’t provided. That documentation is the foundation of every successful worker protection case ever filed.

The source document for this investigation is attached below.

fleurchem logo food
the fleurchem logo kinda reminds me of the biotechnica logo lmao

Explore by category

01

Antitrust

Monopolies and anti-competition tactics used to crush rivals.

View Cases →
02

Product Safety Violations

When companies sell dangerous goods, consumers pay the price.

View Cases →
03

Environmental Violations

Pollution, ecological collapse, and unchecked greed.

View Cases →
04

Labor Exploitation

Wage theft, worker abuse, and unsafe conditions.

View Cases →
05

Data Breaches & Privacy

Misuse and mishandling of personal information.

View Cases →
06

Financial Fraud & Corruption

Lies, scams, and executive impunity that distort markets.

View Cases →
07

Intellectual Property

IP theft that punishes originality and rewards copying.

View Cases →
08

Misleading Marketing

False claims that waste money and bury critical safety info.

View Cases →
Aleeia
Aleeia

I'm Aleeia, the creator of this website.

I have 6+ years of experience as an independent researcher covering corporate misconduct, sourced from legal documents, regulatory filings, and professional legal databases.

My background includes a Supply Chain Management degree from Michigan State University's Eli Broad College of Business, and years working inside the industries I now cover.

Every post on this site was either written or personally reviewed and edited by me before publication.

Learn more about my research standards and editorial process by visiting my About page

Articles: 1804